Access to anti-retroviral drugs, male in Myanmar
Myanmar: Access to anti-retroviral drugs, male was 73.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Myanmar, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Myanmar recorded 73.0% for access to anti-retroviral drugs, male in 2024.
The figure is down 1.4% on the previous year and up 151.7% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Myanmar peaked at 74.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Myanmar 62nd out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Myanmar, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 1.0% | — |
| 2006 | 3.0% | +200.0% |
| 2007 | 4.0% | +33.3% |
| 2008 | 6.0% | +50.0% |
| 2009 | 8.0% | +33.3% |
| 2010 | 11.0% | +37.5% |
| 2011 | 15.0% | +36.4% |
| 2012 | 19.0% | +26.7% |
| 2013 | 23.0% | +21.1% |
| 2014 | 29.0% | +26.1% |
| 2015 | 36.0% | +24.1% |
| 2016 | 43.0% | +19.4% |
| 2017 | 50.0% | +16.3% |
| 2018 | 58.0% | +16.0% |
| 2019 | 64.0% | +10.3% |
| 2020 | 70.0% | +9.4% |
| 2021 | 67.0% | -4.3% |
| 2022 | 72.0% | +7.5% |
| 2023 | 74.0% | +2.8% |
| 2024 | 73.0% | -1.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.2% | 0.0% | 8.0% | 10 |
| 2010s | 34.8% | 11.0% | 64.0% | 10 |
| 2020s | 71.2% | 67.0% | 74.0% | 5 |
Countries ranked near Myanmar
More gender data for Myanmar
- Child population (UN estimates and projections) 12,934 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.5781 % change on previous year (2030)
- Population 43,417 (2030)
- Working-age population (UN estimates and projections) 43,417 (2030)
- Population (UN estimates and projections), annual growth rate 0.7919 % change on previous year (2030)
- Age population, age 00, female, interpolated 421,278 (2025)
- Age population, age 00, male, interpolated 445,429 (2025)
- Age population, age 01, female, interpolated 422,232 (2025)
- Age population, age 01, male, interpolated 446,146 (2025)
- Age population, age 02, female, interpolated 423,553 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Myanmar?
- Access to anti-retroviral drugs, male in Myanmar was 73.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Myanmar?
- The highest recorded value was 74.0% in 2023.
- What is the lowest access to anti-retroviral drugs, male recorded in Myanmar?
- The lowest recorded value was 0.0% in 2000.
- How does Myanmar rank for access to anti-retroviral drugs, male?
- Myanmar ranks 62nd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Myanmar?
- Over the last ten years it is up 151.7%. The long-run trend across the full record is volatile.
- Where does this Myanmar data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.